Pfizer Inc. may fall short in convincing federal regulators that its painkiller Celebrex should receive expanded approval to treat children with a devastating form of arthritis, according to documents ...

The blockbuster arthritis drug Celebrex doesn't protect the stomach from dangerous bleeding ulcers as well as thought, a study suggests. Celebrex and two similar new anti-inflammatory drugs are ...

Back in 2004, a popular arthritis drug called Vioxx was pulled off the market when studies showed daily long-term use could increase the risk of heart attack, stroke and death. “This was one of the ...

Drugmaker Pfizer is seeking permission to sell painkiller Celebrex to children as young as two years old with arthritis. According to the FDA, about 1 in 1,000 children have juvenile rheumatoid ...

NEW YORK – Pfizer Inc. (PFE) said Friday it found an increased risk of heart problems with patients taking its top-selling painkiller Celebrex but added it has no plans follow rival Merck & Co. and ...

A well-known, four-year study found popular arthritis drug Celebrex no more dangerous for the heart than older drugs in its same classification - commonly called NSAIDs. Now, a big-data analysis of ...

The popular arthritis drug Celebrex shows promise for the prevention of breast cancer, Texas researchers report. In a study of 40 women at high risk for breast cancer, six months of treatment with ...